Incidental Mutation 'IGL01318:Rnaseh2a'
ID 73954
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Rnaseh2a
Ensembl Gene ENSMUSG00000052926
Gene Name ribonuclease H2, large subunit
Synonyms 2400006P09Rik
Accession Numbers
Essential gene? Probably essential (E-score: 0.968) question?
Stock # IGL01318
Quality Score
Status
Chromosome 8
Chromosomal Location 85683239-85694498 bp(-) (GRCm39)
Type of Mutation unclassified
DNA Base Change (assembly) C to T at 85691752 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change
Ref Sequence ENSEMBL: ENSMUSP00000150387 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000005292] [ENSMUST00000065049] [ENSMUST00000109733] [ENSMUST00000109734] [ENSMUST00000109736] [ENSMUST00000109738] [ENSMUST00000128972] [ENSMUST00000147812] [ENSMUST00000130902] [ENSMUST00000125893] [ENSMUST00000140561] [ENSMUST00000214133]
AlphaFold Q9CWY8
Predicted Effect probably benign
Transcript: ENSMUST00000005292
SMART Domains Protein: ENSMUSP00000005292
Gene: ENSMUSG00000005161

DomainStartEndE-ValueType
Pfam:Redoxin 7 157 3.9e-20 PFAM
Pfam:AhpC-TSA 8 141 5.6e-44 PFAM
Pfam:1-cysPrx_C 161 196 8.6e-17 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000065049
SMART Domains Protein: ENSMUSP00000066769
Gene: ENSMUSG00000052926

DomainStartEndE-ValueType
Pfam:RNase_HII 31 242 7.1e-54 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000109733
SMART Domains Protein: ENSMUSP00000105355
Gene: ENSMUSG00000005161

DomainStartEndE-ValueType
Pfam:Redoxin 7 159 1.3e-21 PFAM
Pfam:AhpC-TSA 8 141 1.3e-44 PFAM
Pfam:1-cysPrx_C 161 196 8.6e-17 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000109734
SMART Domains Protein: ENSMUSP00000105356
Gene: ENSMUSG00000005161

DomainStartEndE-ValueType
Pfam:Redoxin 7 159 1.3e-21 PFAM
Pfam:AhpC-TSA 8 141 1.3e-44 PFAM
Pfam:1-cysPrx_C 161 196 8.6e-17 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000109736
SMART Domains Protein: ENSMUSP00000105358
Gene: ENSMUSG00000052926

DomainStartEndE-ValueType
Pfam:RNase_HII 31 242 1.3e-51 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000109738
SMART Domains Protein: ENSMUSP00000105360
Gene: ENSMUSG00000052926

DomainStartEndE-ValueType
Pfam:RNase_HII 31 242 5.5e-53 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000122931
Predicted Effect probably benign
Transcript: ENSMUST00000128972
SMART Domains Protein: ENSMUSP00000121864
Gene: ENSMUSG00000052926

DomainStartEndE-ValueType
signal peptide 1 22 N/A INTRINSIC
Pfam:RNase_HII 57 268 1.4e-53 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000147812
SMART Domains Protein: ENSMUSP00000120374
Gene: ENSMUSG00000052926

DomainStartEndE-ValueType
Pfam:RNase_HII 31 242 1.3e-51 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000137791
Predicted Effect noncoding transcript
Transcript: ENSMUST00000143402
Predicted Effect noncoding transcript
Transcript: ENSMUST00000138748
Predicted Effect probably benign
Transcript: ENSMUST00000130902
Predicted Effect probably benign
Transcript: ENSMUST00000125893
SMART Domains Protein: ENSMUSP00000122694
Gene: ENSMUSG00000005161

DomainStartEndE-ValueType
Pfam:Redoxin 7 147 1.4e-21 PFAM
Pfam:AhpC-TSA 8 141 2.3e-45 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000140561
SMART Domains Protein: ENSMUSP00000118442
Gene: ENSMUSG00000052926

DomainStartEndE-ValueType
Pfam:RNase_HII 31 54 4e-12 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000214133
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a component of the heterotrimeric type II ribonuclease H enzyme (RNAseH2). RNAseH2 is the major source of ribonuclease H activity in mammalian cells and endonucleolytically cleaves ribonucleotides. It is predicted to remove Okazaki fragment RNA primers during lagging strand DNA synthesis and to excise single ribonucleotides from DNA-DNA duplexes. Mutations in this gene cause Aicardi-Goutieres Syndrome (AGS), a an autosomal recessive neurological disorder characterized by progressive microcephaly and psychomotor retardation, intracranial calcifications, elevated levels of interferon-alpha and white blood cells in the cerebrospinal fluid.[provided by RefSeq, Aug 2009]
Allele List at MGI

All alleles(33) : Targeted(1) Gene trapped(32)

Other mutations in this stock
Total: 40 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Alg10b T C 15: 90,112,592 (GRCm39) probably benign Het
Ambn T C 5: 88,608,554 (GRCm39) probably benign Het
Asap2 A G 12: 21,297,296 (GRCm39) D585G probably null Het
Chaf1a G T 17: 56,366,336 (GRCm39) probably benign Het
Ddhd1 A G 14: 45,854,008 (GRCm39) S443P probably damaging Het
Dlk2 A G 17: 46,613,390 (GRCm39) E215G probably damaging Het
Efhd2 T C 4: 141,587,176 (GRCm39) N202S probably benign Het
Gkap1 A T 13: 58,384,853 (GRCm39) I308K probably damaging Het
Gm9848 T A 13: 113,244,774 (GRCm39) noncoding transcript Het
Hmcn1 G A 1: 150,594,991 (GRCm39) T1826I probably damaging Het
Htr5a T C 5: 28,047,742 (GRCm39) V99A probably benign Het
Inha T G 1: 75,486,572 (GRCm39) F289C probably damaging Het
Kcna3 T C 3: 106,945,294 (GRCm39) V519A probably benign Het
Kcnma1 A T 14: 23,364,390 (GRCm39) probably benign Het
Kctd1 A G 18: 15,195,747 (GRCm39) V292A possibly damaging Het
Magea13 T A X: 57,964,829 (GRCm39) I196N probably damaging Het
Map2k4 A G 11: 65,647,089 (GRCm39) probably benign Het
Mfap2 G T 4: 140,742,856 (GRCm39) A175S possibly damaging Het
Milr1 G A 11: 106,656,071 (GRCm39) A114T possibly damaging Het
Mogs G T 6: 83,095,558 (GRCm39) V792F probably damaging Het
Nt5dc3 T A 10: 86,661,089 (GRCm39) M418K possibly damaging Het
Or5b12 A G 19: 12,897,490 (GRCm39) L61P probably damaging Het
Or7d10 A G 9: 19,832,054 (GRCm39) E183G probably benign Het
Or8h8 A T 2: 86,753,293 (GRCm39) N194K probably benign Het
Osbpl10 G A 9: 115,061,190 (GRCm39) W756* probably null Het
Pgam5 A G 5: 110,413,391 (GRCm39) Y235H probably damaging Het
Pgm5 G T 19: 24,793,842 (GRCm39) A274E probably damaging Het
Prex1 C A 2: 166,411,260 (GRCm39) probably benign Het
Prps1l1 A T 12: 35,035,377 (GRCm39) N164I probably benign Het
Ralbp1 C A 17: 66,171,277 (GRCm39) R232L probably damaging Het
Stard9 A T 2: 120,529,200 (GRCm39) H1819L possibly damaging Het
Stom T A 2: 35,226,889 (GRCm39) I15F probably benign Het
Tasor2 A C 13: 3,625,067 (GRCm39) S946A possibly damaging Het
Tph1 T G 7: 46,314,662 (GRCm39) T22P probably damaging Het
Uqcrfs1 A G 13: 30,724,904 (GRCm39) I212T probably benign Het
Ush2a T C 1: 188,546,550 (GRCm39) I3442T probably benign Het
Vinac1 C A 2: 128,880,622 (GRCm39) V435L probably benign Het
Vmn2r113 A G 17: 23,177,309 (GRCm39) I698V probably benign Het
Vmn2r75 T C 7: 85,814,774 (GRCm39) I240V probably benign Het
Wdr17 T C 8: 55,125,585 (GRCm39) T432A probably damaging Het
Other mutations in Rnaseh2a
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01773:Rnaseh2a APN 8 85,691,767 (GRCm39) missense probably damaging 1.00
IGL02606:Rnaseh2a APN 8 85,686,723 (GRCm39) missense probably damaging 1.00
P0016:Rnaseh2a UTSW 8 85,686,429 (GRCm39) missense probably damaging 1.00
R1521:Rnaseh2a UTSW 8 85,692,487 (GRCm39) critical splice donor site probably null
R2270:Rnaseh2a UTSW 8 85,692,048 (GRCm39) missense probably benign 0.03
R4226:Rnaseh2a UTSW 8 85,686,702 (GRCm39) missense possibly damaging 0.72
R4227:Rnaseh2a UTSW 8 85,686,702 (GRCm39) missense possibly damaging 0.72
R4763:Rnaseh2a UTSW 8 85,692,021 (GRCm39) missense probably benign 0.02
R5344:Rnaseh2a UTSW 8 85,684,735 (GRCm39) unclassified probably benign
R8000:Rnaseh2a UTSW 8 85,692,678 (GRCm39) unclassified probably benign
R8354:Rnaseh2a UTSW 8 85,691,776 (GRCm39) missense probably benign
R8454:Rnaseh2a UTSW 8 85,691,776 (GRCm39) missense probably benign
R8964:Rnaseh2a UTSW 8 85,686,434 (GRCm39) missense probably benign 0.00
R9710:Rnaseh2a UTSW 8 85,684,638 (GRCm39) missense probably damaging 1.00
R9735:Rnaseh2a UTSW 8 85,686,661 (GRCm39) missense probably damaging 1.00
RF008:Rnaseh2a UTSW 8 85,686,687 (GRCm39) nonsense probably null
Posted On 2013-10-07